Insights

Your Attractive HeadingIn private capital markets, you’ll see the phrase “accredited investors only” everywhere—private placements, growth equity raises, PIPEs, special situations, real estate syndications, and pre-IPO deals. But in practice, the real differentiator isn’t whether someone claims they’re accredited. It’s whether they are truly accredited, properly qualified, and—most importantly—actually capable of funding and supporting an […]

Forward-looking statements are a necessary part of being a public company. Investors want to know where you’re going, not just where you’ve been. But in public markets, “vision” without backup isn’t inspiring—it’s a liability. If you give guidance, publish projections, talk about expected revenue, margins, acquisitions, product launches, pipeline conversion, or “path to profitability,” you’re

In April 2012, Congress passed the Jumpstart Our Business Startups (JOBS) Act, a landmark set of reforms intended to make it easier for growing companies to raise capital—both privately and in the public markets—by expanding offering options, modernizing disclosures, and reducing certain early-stage regulatory burdens. The SEC maintains a central hub with the Act’s rulemakings,

In certain holding-company strategies, the goal isn’t just to buy and hold operating businesses—it’s to acquire, incubate, then spin out a matured subsidiary so it can stand alone with its own shareholder base and market identity. A practical structure we see more often (especially in small-cap and cross-border deal ecosystems) is what we’ll call a

Reverse mergers (reverse takeovers / RTOs) can be one of the most efficient routes to public markets—or one of the fastest ways to destroy shareholder value. The structure itself is neutral. What matters is execution quality: capitalization discipline, audit readiness, disclosure controls, market-structure awareness, and a plan to avoid toxic financing dynamics. Below are notable

Stock swaps show up everywhere in the middle market: roll-ups, public-company acquisitions, reverse mergers, “strategic” combinations, even vendor settlements. The pitch is usually the same: Sometimes that’s true. But a stock swap is not value creation by default—it’s a payment method. Whether it adds value depends on what you’re buying, what you’re issuing, and whether

How state securities rules intersect with federal exemptions—and what issuers must do to stay compliant. When companies think about “securities compliance,” they usually start with the SEC. But in the U.S., securities regulation is a two-layer system: the federal rules are only half the story. The other half is a patchwork of state securities laws,

State “Blue Sky” laws were built to protect investors by regulating securities offers and sales within each state. In the secondary trading context, however, they can also create a patchwork of rules that affects whether broker-dealers and investment advisers can research, recommend, and facilitate trading in a company’s securities—especially for OTC-traded issuers. In a September

OTC Markets Group has been steadily re-shaping the OTC ecosystem to make it easier for investors, brokers, and regulators to distinguish engaged, disclosure-forward issuers from companies that provide little (or no) current information. The most meaningful step in that evolution is the launch of OTCID—a new basic reporting market that replaces the long-familiar Pink Current

The Sarbanes-Oxley Act of 2002—better known as SOX—is one of the most important laws shaping how U.S. public companies report financial results, manage risk, and prove credibility to investors. It was enacted in the wake of major accounting scandals to restore confidence in public markets by strengthening oversight, accountability, and internal controls. If you’re a